Literature DB >> 2734822

Granulocyte transfusion therapy in a child with chronic granulomatous disease and multiple red cell alloantibodies.

L Depalma1, S F Leitman, C S Carter, J I Gallin.   

Abstract

A 7-year-old, 17-kg child with chronic granulomatous disease and nocardial pneumonia and osteomyelitis did not respond to antibiotic therapy and developed multiple red cell (RBC) alloantibodies (anti-c, -E, and -Jka). To provide daily granulocyte concentrates, a method was devised to reduce the number of incompatible RBCs per transfusion. Leukapheresis was done with hydroxyethyl starch, and the apheresis product was allowed to sediment by gravity in a plasma expressor for 90 minutes. The leukocyte-rich plasma was separated from the sedimented RBCs by transfer to a satellite bag, and the volume of the product was reduced by centrifugation to approximately 80 ml. RBC content was reduced from 29 +/- 7 to 2.5 +/- 1.0 ml (n = 22, p less than 0.01) and was accompanied by a 70 percent recovery of white cells (range, 49-90%). The final product contained 1.6 +/- 1.0 X 10(10) granulocytes. There were no clinical or laboratory signs of hemolysis during the course of 46 granulocyte transfusions, 37 of which were derived from c-, E-, or Jka-positive donors. The size of most apheresis donor pools is insufficient to provide phenotypically matched granulocyte concentrates daily for patients with RBC alloimmunization. The rapid, simple method described here may allow daily therapy with mismatched concentrates to be administered safely to such patients.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2734822     DOI: 10.1046/j.1537-2995.1989.29589284143.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  4 in total

1.  Granulocyte transfusion therapy: randomization after all?

Authors:  Agata Drewniak; Taco W Kuijpers
Journal:  Haematologica       Date:  2009-12       Impact factor: 9.941

2.  NADPH oxidase correction by mRNA transfection of apheresis granulocytes in chronic granulomatous disease.

Authors:  Suk See De Ravin; Julie Brault; Ronald J Meis; Linhong Li; Narda Theobald; Aylin C Bonifacino; Hong Lei; Taylor Q Liu; Sherry Koontz; Cristina Corsino; Marissa A Zarakas; Jigar V Desai; Aaron B Clark; Uimook Choi; Mark E Metzger; Kamille West; Steven L Highfill; Elizabeth Kang; Douglas B Kuhns; Michail S Lionakis; David F Stroncek; Cynthia E Dunbar; John F Tisdale; Robert E Donahue; Gary A Dahl; Harry L Malech
Journal:  Blood Adv       Date:  2020-12-08

3.  The relationship between alloimmunization and posttransfusion granulocyte survival: experience in a chronic granulomatous disease cohort.

Authors:  K F Heim; T A Fleisher; D F Stroncek; S M Holland; J I Gallin; H L Malech; S F Leitman
Journal:  Transfusion       Date:  2010-12-22       Impact factor: 3.157

4.  Gravity sedimentation of granulocytapheresis concentrates with hydroxyethyl starch efficiently removes red blood cells and retains neutrophils.

Authors:  Barbara J Bryant; Yu Ying Yau; Phyllis J Byrne; David F Stroncek; Susan F Leitman
Journal:  Transfusion       Date:  2010-01-22       Impact factor: 3.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.